Kraft Heinz is reportedly considering selling the ownership of Complan in India, where the US food giant owns the brand.

Citing unnamed sources, Bloomberg yesterday (18 June) reported Kraft Heinz was working with advisers to see what interest there is in owning Complan, under which, in India, the company markets milk drinks targeted at children.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

Kraft Heinz could not be reached for immediate comment.

The Complan business in the UK is now unrelated to Kraft Heinz’s Complan assets in India. In the UK, Complan is a company marketing drinks and soups predominantly for adult consumers and is owned by Danone.

Over the weekend, UK newspaper The Sunday Telegraph said Kraft Heinz had held early discussions on a possible move to buy the food and drinks brand Horlicks, owned by UK-based pharmaceutical group GlaxoSmithKline.

See Also:

In March, GSK said it was reviewing its options over its portfolio of consumer healthcare nutrition products.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Central to the assets under review is GSK’s 72.5% stake in Indian arm GlaxoSmithKline Consumer Healthcare. GSK said the majority of the annual sales made from Horlicks and the other nutrition products – which stood at around GBP550m (US$726.2m) in 2017 – are made in India.